Pink Sheet is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

Bergen Brunswig

Executive Summary

Write off of $505 mil. on Bergen's long-term care pharmacy provider PharMerica recorded in fiscal fourth quarter recognizes that "the price that we paid for this business was too high," the company said during a Nov. 3 conference call. Bergen completed the acquisition, valued at about $1.4 bil. including assumption of debt, in April 1999. The write off was based on a decline in gross profit margins to around 35%. The company's "outlook is that those gross profit margins are not going to go back up to the historical 40% range," Bergen Exec VP Neil Dimick said. Bergen also wrote off $67 mil. for "doubtful receivables" from two long-term care customers
Advertisement
Advertisement
UsernamePublicRestriction

Register

PS036837

Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel